An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004-2018).

Konwar, Mahanjit; Maurya, Mitesh R; Nishandar, Tushar B; Thatte, Urmila M; Gogtay, Nithya J

Konwar, Mahanjit; Maurya, Mitesh R; Nishandar, Tushar B; Thatte, Urmila M; Gogtay, Nithya J.

Afiliação

Konwar M; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Maurya MR; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Nishandar TB; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Thatte UM; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Gogtay NJ; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.

Perspect Clin Res ; 12(3): 159-164, 2021.

Article em En | MEDLINE | ID: mdl-34386381

Palavras-chave

Absolute drug lag; Central Drugs Standard Control Organization; European Medicines Agency; Pharmaceuticals and Medical Devices Agency; United States Food and Drug Administration; relative drug lag

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Perspect Clin Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google